Literature DB >> 24024002

Treatment of digit ulcers in a patient with Buerger's disease by using cervical spinal cord stimulation -a case report-.

Sang-Wook Ryu1, Hee-Jung Jeon, Sam-Soon Cho, Rak-Min Choi, Jin-Sun Yoon, Hong-Seok Ko, Jae-Do Lee.   

Abstract

Buerger's disease (thromboangiitis obliterans) is known as a segmental inflammatory vasculitis that involves the small-sized and medium-sized arteries, veins, and nerves. Most effective treatment for Buerger's disease is smoking cessation. Except for the cessation of tobacco use, surgical revascularization is available in severe ischemia and a distal target vessel. Amputation has been used as the last treatment option of the disease up to the present. Increasing limb survival and decreasing amputation rate is important. This case describes the use of spinal cord stimulation (SCS) in patient with Buerger's disease and its effect is not only the complete healing of ulcers but also amputation is not performed.

Entities:  

Keywords:  Electric stimulation; Thromboangiitis obliterans; Ulcer

Year:  2013        PMID: 24024002      PMCID: PMC3766785          DOI: 10.4097/kjae.2013.65.2.167

Source DB:  PubMed          Journal:  Korean J Anesthesiol        ISSN: 2005-6419


  14 in total

1.  Spinal cord stimulation--a long-term evaluation in patients with chronic pain.

Authors:  A D Kay; M D McIntyre; W A Macrae; T R Varma
Journal:  Br J Neurosurg       Date:  2001-08       Impact factor: 1.596

2.  Spinal cord stimulation in the treatment of peripheral vascular disease: results of a single-center study of 258 patients.

Authors:  Svante Horsch; Stefan Schulte; Stefan Hess
Journal:  Angiology       Date:  2004 Mar-Apr       Impact factor: 3.619

Review 3.  Stimulation of the central and peripheral nervous system for the control of pain.

Authors:  M Stanton-Hicks; J Salamon
Journal:  J Clin Neurophysiol       Date:  1997-01       Impact factor: 2.177

Review 4.  Buerger's disease: diagnosis and management.

Authors:  S Shionoya
Journal:  Cardiovasc Surg       Date:  1993-06

5.  The role of epidural spinal cord stimulation in the treatment of Buerger's disease.

Authors:  Konstantinos P Donas; Stefan Schulte; Kiriakos Ktenidis; Svante Horsch
Journal:  J Vasc Surg       Date:  2005-05       Impact factor: 4.268

6.  Role of nitric oxide in cutaneous blood flow increases in the rat hindpaw during dorsal column stimulation.

Authors:  J E Croom; R D Foreman; M J Chandler; M C Koss; K W Barron
Journal:  Neurosurgery       Date:  1997-03       Impact factor: 4.654

7.  Thoracoscopic sympathectomy for symptomatic arterial obstruction of the upper extremities.

Authors:  Tiziano De Giacomo; Erino A Rendina; Federico Venuta; Domenico Lauri; Edoardo S Mercadante; Marco Anile; Giorgio F Coloni
Journal:  Ann Thorac Surg       Date:  2002-09       Impact factor: 4.330

8.  Oral iloprost in the treatment of thromboangiitis obliterans (Buerger's disease): a double-blind, randomised, placebo-controlled trial. The European TAO Study Group.

Authors: 
Journal:  Eur J Vasc Endovasc Surg       Date:  1998-04       Impact factor: 7.069

9.  Use of a transcutaneous PO2 regional perfusion index to quantify tissue perfusion in peripheral vascular disease.

Authors:  C J Hauser; W C Shoemaker
Journal:  Ann Surg       Date:  1983-03       Impact factor: 12.969

10.  Release of neurotransmitters in the CNS by spinal cord stimulation: survey of present state of knowledge and recent experimental studies.

Authors:  B Linderoth; C O Stiller; L Gunasekera; W T O'Connor; J Franck; B Gazelius; E Brodin
Journal:  Stereotact Funct Neurosurg       Date:  1993       Impact factor: 1.875

View more
  2 in total

1.  Epidural anesthesia for permanent spinal cord stimulation with a cylindrical type lead: a case series.

Authors:  Sang Eun Lee; Rak Min Choi; Rim Kee; Kang Hun Lee; Sangyoon Jeon; Jae-Wook Jung; Woo-Jin Kim; Jin Sun Yoon
Journal:  Korean J Anesthesiol       Date:  2015-03-30

2.  Spinal cord stimulation: panacea for incurable diseases?

Authors:  Jae Hang Shim
Journal:  Korean J Anesthesiol       Date:  2013-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.